baber/WOPTO huggingface dataset:
Patent AU-2019201130-A1 (AU)
Title: Automated coverslipper and methods of use
Inventor: EWONIUK AARON MICHAEL
IPC: G02B21/34
Filed: 2019-02-18
Abstract: AUTOMATED COVERSLIPPER AND METHODS OF USE Abstract An automated coverslipper for mounting a coverslip (490) on a slide, comprising: at least one coverslip (490); at least one slide containing a biological specimen; and at least one lifter head (110, 111) comprising a plate (100) having a bottom surface (120, 121) with at least three individually controlled suction cups (130, 131, 132, 133, 134, 135) arranged thereon, each of said suction cups (130, 131, 132, 133, 134, 135) being fluidly connected, by way of a gas conduit (140, 142, 144), to a pneumatics module, which includes a vacuum source, a pressure source, a pressure sensor, and an independently operable control valve for each gas conduit, said pneumatics module being configured to supply an independent vacuum or pressurized gas to each suction cup (130, 131, 132, 133, 134, 135) to enable the lifter head (110, 111) to pick up, transport, and deposit the coverslip (490) on the slide, and wherein at least one of said independently operable control-valves is configured to allow both an immediate release of vacuum and a gradual release of vacuum, wherein the bottom surface (120, 121) of the lifter head (110, 111) has a shape selected from the group consisting of concave, convex, dual chamfer and combinations thereof.
Patent AU-2019201453-A1 (AU)
Title: Method and apparatus for determining medication dose information
Inventor: TAUB MARC BARRY
IPC: A61M31/00
Filed: 2019-03-01
Abstract: A method of using data from an in vivo analyte sensor of an electronic analyte monitoring system to determine and administer a bolus insulin dose is disclosed, comprising: positioning at least a portion of the in vivo analyte sensor in contact with interstitial fluid in a body of a user; using the electronic analyte monitoring system to determine bolus insulin dose information by: receiving, at one or more processors, analyte data related to an analyte level of a user from an in vivo analyte sensor; determining, using the one or more processors, an analyte level of the user from the received analyte data; determining a rate of change of the analyte level of the user using the received analyte data and prior analyte data; determining, using the one or more processors, a recommended bolus insulin dose based at least in part upon the determined analyte level of the user; and modifying, using the one or more processors, the recommended bolus insulin dose based at least in part upon a lag between an interstitial fluid analyte level and blood analyte level; and administering a bolus to the user based at least in part on the modified recommended bolus insulin dose.
Patent AU-2019210633-A1 (AU)
Title: Mobile multifactor single-sign-on authentication
Inventor: PHILLIPS ROBERT JASON
IPC: G06F21/41
Filed: 2019-08-02
Abstract: Features are disclosed for authentication of mobile device applications using a native, independent browser using a single-sign-on system. An authentication module within the mobile application can direct the mobile device's native browser to a URL to initiate authentication with an authentication appliance. The mobile browser can receive and store a browser-accessible token to indicate previous authentication performed by the user. The mobile application can receive from the application appliance and store a client application ID token that may be presented to network services for access. A second mobile device application may direct the same browser to the authentication appliance. The authentication appliance may inspect the persistent browser-accessible token and issue a second client application ID identity to the second application without collecting additional authentication information, or collecting additional authentication information that is different from the first authentication information.
Patent AU-2019213384-A1 (AU)
Title: Anti-vista antibodies and fragments
Inventor: SNYDER LINDA
IPC: A61K39/395
Filed: 2019-08-08
Abstract: The present invention relates to novel antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of making and using same. Methods of use include methods of treatment of cancer, including leukemias, lymphomas, solid tumors and melanomas.
Patent AU-2019226165-A1 (AU)
Title: Tip-loaded microneedle arrays for transdermal insertion
Inventor: FALO JR
IPC: A61M37/00
Filed: 2019-09-04
Abstract: A method of forming a microneedle array can include forming a microneedle array that has one or more bioactive component. The microneedle array can include a base portion and plurality of microneedles extending from the base portion, and the one or more bioactive components are present in a higher concentration in the plurality of microneedles than in the base portion.
Patent AU-2019229469-A1 (AU)
Title: GLP-1 composition for treating obesity and weight management
Inventor: YU ZHIWEN
IPC: A61K38/26
Filed: 2019-03-08
Abstract: Uses of a recombinant human GLP-1 peptide, the uses include preventing or treating obesity and/or over weight, and managing body weight. The therapeutically effective amount of the GLP-1 peptide is from about 0.11 mg/day to about 0.66 mg/day.
Patent AU-2019261673-A1 (AU)
Title: Method for controlling a coffee grinder
Inventor: DUNKELBERG OLIVER
IPC: A47J42/44
Filed: 2019-11-04
Abstract: Method for controlling an automatic coffee bean grinder (2) which is separate from an 5 automatic coffee brewing machine (1) using ground coffee produced by said coffee bean grinder (2), is disclosed, wherein a flowmeter sniffer element (15) is located in or at a housing (3) of said coffee brewing machine (1) is capturing the water flow-through information measured by a water flowmeter (5) of said coffee brewing machine (1), and transmits the water flow-through information to a grinder control unit (26) located in the 10 automatic coffee bean grinder (2), and the grinder control unit (26) controls the grinder module (24) as a function of the water flow-through information transmitted from said flowmeter sniffer element (15). (Fig. 1) 15' 17 3 18 --------------- ------- | 1 -- ~ 13 14:] 8 `15 -22 E----J 26 - -- 23
Patent AU-2019263297-A1 (AU)
Title: Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma
Inventor: COOK ROBERT WILLIS
IPC: C40B40/06
Filed: 2019-05-01
Abstract: The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis in primary cutaneous squamous cell carcinoma (cSCC).
Patent AU-2019275669-A1 (AU)
Title: Self adhesive fouling release coating composition
Inventor: MICHEL GAUTIER
IPC: C09D5/16
Filed: 2019-12-06
Abstract: Abstract A multilayer self-adhesive fouling release coating composition comprising the following layers: (i) an optional removable underlying liner; (ii) an adhesive layer applied over and to the optional underlying liner when the latter is present; (iii)a synthetic material layer applied over and to the adhesive layer (ii); (iv)optionally, an intermediate silicone tie coat applied over and to the synthetic material layer (iii); (v) a silicone fouling release top coat applied over and to the synthetic material layer (iii), or, when present, over and to the intermediate silicone tie coat (iv); and optionally (vi)a removable polymeric film applied over and to the fouling release top coat (v).
Patent AU-2019284446-A1 (AU)
Title: Diverging/merging device for conveying equipment
Inventor: FUJIO YOSHIHIKO
IPC: B65G47/54
Filed: 2019-04-05
Abstract: In this transportation equipment branch convergence device, a curving transportation device 8 that tangentially connects to a straight track is anchored at a fixed height so as to transport an object for transport along the entirety of a curving track at the same level as the straight track. The straight track comprises a straight track section 7 of a fixed length encompassing an entire area of overlap with the curving transportation device 8. A straight transportation device 9 constituting this straight track section 7 of fixed length comprises vertical transportation means 17, 19, 20 that slope in the vertical direction with pivot points at both ends of the straight track section 7 of fixed length. When the vertical transportation means 17, 19, 20 are in a downward sloping state, the straight transportation device 9 is retracted beneath the transported object for transport. When the vertical transportation means 17, 19, 20 are in an upward sloping state, the transported object for transport passes over the curving transportation device 8.
Patent AU-2019293570-A1 (AU)
Title: Beer-taste beverage having enhanced crisp aftertaste
Inventor: KOJIMA Kyosuke
IPC: A23L2/56
Filed: 2019-06-27
Abstract: Disclosed is a beer-taste beverage that satisfies at least one condition selected from the group consisting of: (a) the concentration of 1-phenyl-3-buten-1-one is at least 10 ppb; (b) the concentration of trans-2-hexenal is at least 5 ppb; and (c) the concentration of nonanal is at least 1 ppb. This beer-taste beverage provides an enhanced crisp aftertaste.
Patent AU-2019295815-A1 (AU)
Title: Blockchain-based data verification method and apparatus, and electronic device
Inventor: YE GUOJUN
IPC: H04L9/32
Filed: 2019-03-28
Abstract: Provided in one or more embodiments of the present application are a blockchain-based data verification method and apparatus, and an electronic device. The method may comprise: acquiring a data identifier of target data disclosed by a data provider on a blockchain; wherein the data identifier indicates a storage position of the target data on the blockchain; determining whether the target data is stored on the blockchain on the basis of the data identifier; if the target data is stored on the blockchain, acquiring the target data from the storage position indicated by the data identifier; wherein the target data stored on the blockchain carries authentication information for verifying the authenticity of the target data; and verifying the authenticity of the acquired target data on the basis of the authentication information and outputting a verification result to a data verifier.
Patent AU-2019337286-A1 (AU)
Title: Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing GPR119 ligand as active ingredient
Inventor: KIM MI-KYUNG
IPC: A61K31/445
Filed: 2019-09-11
Abstract: The present invention pertains to a pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, the composition containing G protein coupled receptor 119 (GPR119) ligand as an active ingredient. The pharmaceutical composition according to the present invention exhibits the excellent effects of improving lipid metabolism, reducing fat accumulation in liver tissues, and preventing histological damage caused by inflammation and fibrosis in liver tissues, and can thus be useful in preventing or treating nonalcoholic fatty liver disease.
Patent AU-2019342668-A1 (AU)
Title: Door hanger bracket
Inventor: GILL RYAN L
IPC: E06B1/60
Filed: 2019-02-13
Abstract: A door assembly, a hanger bracket therefor which comprises an elongated manually bendable body which extends from a first wall mounting tab at one end, for a distance approximately equal to the width of a door jamb, and sufficiently far beyond to provide for forming a second wall mounting tab. The elongated body includes at least one bend line extending laterally with respect to the length of said body, whereby the body can be manually bent to form said second wall mounting tab, after the bracket has been secured to the jamb of the door assembly and the door assembly located in the door opening of the wall and secured to one side of the wall by the first wall mounting tab. Two bend lines are shown such that the bracket can be used in a wall having drywall on both sides, or in a wall having drywall on only one side.
Patent AU-2019366076-A1 (AU)
Title: Anti-obesity agent, pollakiuria improving agent, and autonomic nervous activity regulator
Inventor: OHKI KOHJI
IPC: A61P1/12
Filed: 2019-10-17
Abstract: [Problem] The purpose of the present invention is to provide a novel technique associated with anti-obesity improvement. [Solution] The present invention relates to an anti-obesity agent comprising lactononadecapeptide (LNDP, Asn-Ile-Pro-Pro-Leu-Thr-Gln-Thr-Pro-Val-Val-Val-Pro-Pro-Phe-Leu-Gln-Pro-Glu) or a salt thereof. The present invention also relates to a pollakiuria improving agent and an autonomic nervous activity regulator each comprising LNDP.
Patent AU-2019405747-A1 (AU)
Title: Bispecific anti-CD28 x anti-CD22 antibodies and uses thereof
Inventor: MURPHY ANDREW J
IPC: A61P35/02
Filed: 2019-12-18
Abstract: The present invention provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds human CD28, and a second antigen- binding molecule that specifically binds human CD-22. In certain embodiments, the bispecific antigen- binding molecules of the present invention are capable of inhibiting the growth of tumors expressing CD-22, such as B-cell lymphomas. The antibodies and bispecific antigen-binding molecules of the invention are useful for the treatment of diseases and disorders in which an up-regulated or induced targeted immune response is desired and/or therapeutically beneficial.
Patent AU-2019417448-A1 (AU)
Title: Method for detecting presence of tubing in pump assembly
Inventor: WANG RUOYA
IPC: G05B15/02
Filed: 2019-12-19
Abstract: Methods for detecting tubing in a pump assembly of a pump system are provided. For example, a method comprises connecting a power supply to each of a plurality of pump motors of the pump system. Each pump motor of the plurality of pump motors has a power supply cable configured to connect to the power supply and drives a pump head of a plurality of pump heads of the pump system. The method also comprises sensing a motor current from each of the power supply cables, determining whether tubing is loaded in each pump head, and, if tubing is not loaded in a pump head, then disconnecting from the power supply the power supply cable of the pump motor associated with the pump head in which tubing is not loaded. Systems for detecting the presence of tubing within a pump head of a plurality of pump heads also are provided.
Patent AU-2019417986-A1 (AU)
Title: Biochemical diagnostic test for attention-deficit/hyperactivity disorder (ADHD)
Inventor: HENRÍQUEZ MARCELA
IPC: G01N33/92
Filed: 2019-01-03
Abstract: The invention relates to a biochemical diagnostic test conducted on peripheral blood, which makes it possible to diagnose Attention-Deficit/Hyperactivity Disorder (ADHD). It specifically measures the serum levels of at least six markers corresponding to two functional lipid groups, specifically sphingolipids and long-chain polyunsaturated fatty acids (LC-PUFAs). C16:0 ceramide, C24:0 ceramide, C24:1 deoxy-(dihydro)ceramide and sphinganine 1-phosphate, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), detecting a variation in concentrations with respect to the values for the control population.
Patent AU-2019422940-A1 (AU)
Title: Rotating machine, outdoor unit of air-conditioning apparatus, and air-conditioning apparatus
Inventor: NOMOTO Kazuma
IPC: H02K21/12
Filed: 2019-01-17
Abstract: This rotating machine is provided with: an electric motor having a stator and a rotor that has a rotor core formed of a magnetic material, a plurality of permanent magnets attached to the rotor core mutually at intervals in the circumferential direction while orienting the same magnetic pole toward the outside in the radial direction, and a shaft formed of a magnetic material, provided extending in the axial direction at the central portion of the rotor core, and magnetized by a part of the magnetic fluxes generated from the plurality of permanent magnets and is disposed rotatably with respect to the stator; a member-to-be-rotated provided on the shaft; and a fastening member formed of a magnetic material and fastening the member-to-be-rotated to the shaft.
Patent AU-2019461161-A1 (AU)
Title: Ue capability information reporting method and device
Inventor: ZHU PENG
IPC: H04W76/15
Filed: 2019-09-04
Abstract: Provided are a method and device for reporting user equipment (UE) capability information, wherein same relate to the technical field of communications and can solve the problem whereby if a UE supports a band combination composed of an intra-band evolved universal terrestrial radio access and new radio dual-connectivity (ENDC) band combination and new radio carrier aggregation (NRCA), the UE cannot report a bandwidth combination set of NRCA corresponding to the band combination. The method comprises: a UE receiving UE capability enquiry information from a network device, wherein the UE capability enquiry information is used for enquiring about the capability of the UE; and the UE sending UE capability information to the network device according to the UE capability enquiry information, wherein the UE capability information is used for indicating that the UE supports a first-type band combination, the first-type band combination comprises a band combination composed of an intra-band ENDC band combination and NRCA, the UE capability information comprises first information and second information, the first information comprises a first bandwidth combination set of the intra-band ENDC supported by the UE, and the second information comprises a second bandwidth combination set of the NRCA supported by the UE.
Patent AU-2019470252-A1 (AU)
Title: Test strip and method for measuring urine Aβ amyloid protein
Inventor: DAI ZHENGQIAN
IPC: G01N33/68
Filed: 2019-10-15
Abstract: A test strip and method for measuring urine Aβ amyloid protein. The test strip for measuring the urine Aβ amyloid protein comprises a PVC bottom plate (7), wherein a sample pad (1), a conjugated pad (2), a chromatography pad (3), and a water absorption pad (4) which are sequentially overlapped are paved on the PVC bottom plate (7); the conjugated pad (2) is coated with colloidal gold particles conjugated with a monoclonal antibody; a measurement line (5) is provided on one side, close to the conjugated pad (2), of the chromatography pad (3); a contrast control line (6) is provided on one side, close to the water absorption pad (4), of the chromatography pad (3); the measurement line (5) is coated with an Aβ amyloid protein binding polymer; and the contrast control line (6) is coated with a goat anti-mouse IgG polyclonal antibody. The method is high in sensitivity, has a measurement limit of 40 pg, is rapid and economical, is suitable for conventional clinical pathological examination, is suitable for general screening of a large number of people and self-screening of home terminal users, is especially used for clinically assisting early diagnosis and pre-determination of mild cognitive impairment (MCI), and predicts and determines whether a patient has high risk of developing MCI and AD.
Patent AU-2020220127-A1 (AU)
Title: Aseptic piercing system and method
Inventor: ARNOTT RACHEL PAIGE
IPC: A61M5/24
Filed: 2020-08-20
Abstract: ) The present disclosure provides aseptic vial piercing and sterilization systems, and methods 
of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized 
primary container including a first end, a first cavity, a second end with an opening in 
communication with the first cavity, a septum at least partially sealing the opening, and a 
product within the first cavity. The systems and methods include an injection assembly 
including a first end portion of a hollow flowpath forming member. The injection assembly 
and the primary container may be assembled in a non-sterile environment to form a second 
cavity extending about the first end portion of the flowpath forming member and to the 
primary container. The second cavity may then be selectively sterilized in a non-deleterious 
manner to the product to allow the first end portion to aseptically pierce the septum to extend 
into the first cavity.
Patent AU-2020240068-A1 (AU)
Title: Systems and methods for compact laser wakefield accelerated electrons and X-rays
Inventor: TAJIMA TOSHIKI
IPC: A61B6/00
Filed: 2020-03-18
Abstract: A laser wakefield acceleration (LWFA) induced electron beam system for cancer therapy and diagnostics. Example embodiments presented herein include one or more laser fibers, and an electron beam source within an individual one of the one or more laser fibers, wherein the electron beam source includes a laser pulse source, a plasma target, a set of optics interposing the laser pulse source and the plasma target adapted to focus a laser pulse generated by the laser pulse source onto the plasma target, wherein interaction of the laser pulse with the plasma target induces the generation of an electron beam. In various embodiments presented herein, high energy electrons of the electron beam interact with a high-Z material to generate X-rays.
Patent AU-2020244463-A1 (AU)
Title: Endoglin peptides to treat fibrotic diseases
Inventor: GRINBERG ASYA
IPC: A61K38/17
Filed: 2020-09-30
Abstract: In certain aspects, the present disclosure relates to the insight that a 
polypeptide comprising a truncated, ligand-binding portion of the extracellular 
5 domain of endoglin (ENG) polypeptide may be used to treat fibrotic disorders.
Patent AU-2020259982-A1 (AU)
Title: Bispecific antibodies
Inventor: GANDHI PRAFULL S
IPC: C07K16/28
Filed: 2020-04-15
Abstract: The invention relates to a bispecific antibody comprising a first antigen-binding site capable of binding Factor VII(a) and a second antigen-binding site capable of binding TLT-1, pharmaceutical formulations comprising such bispecific antibodies and uses thereof.
Patent AU-2020268212-A1 (AU)
Title: A fire barrier assembly and method of use thereof
Inventor: DAY SIMON
IPC: A62C2/06
Filed: 2020-05-08
Abstract: The present invention concerns a deployable fire barrier assembly, system and method of use for at least partially impeding the spread of fire along an external surface of a structure during a fire event. In one form, the assembly includes a frame mountable to the external surface of the structure; and a barrier movably coupled to the frame and configured to be deployable from a non-operable position in which the barrier is stowed against the external surface of the structure to an operable position in which the barrier extends outwardly from the structure to at least partially impede the fire.
Patent AU-2020281866-A1 (AU)
Title: Electric motor and assembly method for electric motor
Inventor: PENG LIANG
IPC: H02K1/12
Filed: 2020-01-19
Abstract: The present application relates to an electric motor and an assembly method for an electric motor. The electric motor comprises: a shaft system which comprises a first shaft, a second shaft coaxially arranged at the inner periphery of the first shaft, and a bearing arranged between the first shaft and the second shaft; a first rotary body, which is coaxially connected to the first shaft, wherein the first rotary body comprises an annular first adapter support, and a cylindrical structure part extending in an axial direction is arranged at the inner periphery of the first adapter support; a second rotary body, which is coaxially connected to the second shaft, wherein the second rotary body is sleeved on the outer periphery of the first rotary body; and a guide assembly arranged between the cylindrical structure part and the first shaft so as to limit the circumferential and radial movement of the first rotary body relative to the first shaft. According to the electric motor, the coaxiality of a stator or a rotor with respect to the shaft system is improved, and the assembly quality of the electric motor is thus improved; and the guide assembly replaces sleeving tooling, so that the assembly process of the electric motor is simplified, and similarly, the assembly cost of the electric motor is reduced.